Better detection of platelet aggregation in patients with metabolic syndrome using epinephrine and ADP.

Background: Patients with metabolic syndrome (MS) often have increased platelet aggregation. In order to determine which concentration detects a higher level of platelet aggregation in patients with MS, the agonists ADP and epinephrine were compared.

Methods: The study included 56 subjects with MS and 53 healthy subjects.